Zhang B - Search Results

1

Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?

Mi JL, Zhang B, Pan YF, Su YX, Fan JF, Liao SF, Qin XL, Yao DC, Tang HY, Jiang W. Mi JL, et al. Among authors: zhang b. Oral Oncol. 2017 Nov;74:34-39. doi: 10.1016/j.oraloncology.2017.09.003. Oral Oncol. 2017. PMID: 29103749

2

Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.

Zhang B, Hu Y, Xiong RH, Pan YF, Xu QL, Kong XY, Cai R, Chen QQ, Tang HY, Jiang W. Zhang B, et al. Oncotarget. 2017 Feb 21;8(8):14078-14088. doi: 10.18632/oncotarget.13285. Oncotarget. 2017. PMID: 27845907 Free PMC article.

3

Comparison of intensity-modulated radiation therapy alone vs. intensity-modulated radiation therapy combined with chemotherapy in elderly nasopharyngeal carcinoma patients (aged >65 years).

Mi JL, Meng YL, Wu HL, Cao YL, Zhang B, Pan YF, Zhou YY, Fan JF, Liao SF, Qin XL, Yao DC, Jiang W. Mi JL, et al. Among authors: zhang b. Strahlenther Onkol. 2020 Mar;196(3):270-279. doi: 10.1007/s00066-019-01533-7. Epub 2019 Nov 20. Strahlenther Onkol. 2020. PMID: 31748837 English.

4

Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma.

Aftab O, Liao S, Zhang R, Tang N, Luo M, Zhang B, Shahi S, Rai R, Ali J, Jiang W. Aftab O, et al. Among authors: zhang r, zhang b. Radiat Oncol. 2020 Mar 16;15(1):66. doi: 10.1186/s13014-020-01508-4. Radiat Oncol. 2020. PMID: 32178698 Free PMC article.

5

Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.

Qin G, Rai R, Zhang R, Su Y, Zhang B, Pan Y, Xiong R, Xie Y, Yang H, Kong X, Luo Z, Ruan X, Mo Y, Aftab O, Shahisanjeev, Jazib, Jiang W. Qin G, et al. Among authors: zhang r, zhang b. Oral Oncol. 2020 Jul;106:104704. doi: 10.1016/j.oraloncology.2020.104704. Epub 2020 Apr 21. Oral Oncol. 2020. PMID: 32330685

6

Impact of the weekday of the first intensity-modulated radiotherapy treatment on the survival outcomes of patients with nasopharyngeal carcinoma: A multicenter cohort study.

Mo Y, Zhang B, Pan Y, Qin Q, Ye Y, Li X, Huang L, Jiang W. Mo Y, et al. Among authors: zhang b. Oral Oncol. 2021 May;116:105258. doi: 10.1016/j.oraloncology.2021.105258. Epub 2021 Mar 9. Oral Oncol. 2021. PMID: 33706048

7

Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.

Xu QL, Luo Z, Zhang B, Qin GJ, Zhang RY, Kong XY, Tang HY, Jiang W. Xu QL, et al. Among authors: zhang ry, zhang b. Cancer Sci. 2021 Oct;112(10):4127-4138. doi: 10.1111/cas.15103. Epub 2021 Aug 19. Cancer Sci. 2021. PMID: 34382305 Free PMC article.

8

Effects and Mechanism of Oxymatrine Combined with Compound Yinchen Granules on the Apoptosis of Hepatocytes through the Akt/FoxO3a/Bim Pathway.

Zhang X, Ge J, Zhu X, Zhang H, Wang Y, Xu T, Jiang W, Zhang B. Zhang X, et al. Among authors: zhang b, zhang h. Biomed Res Int. 2022 Jan 6;2022:8644356. doi: 10.1155/2022/8644356. eCollection 2022. Biomed Res Int. 2022. PMID: 35036441 Free PMC article.

9

Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.

Yang H, Zhang R, Zhang R, Zhang B, Xie Y, Qin G, Mo Y, Ruan X, Jiang W. Yang H, et al. Among authors: zhang r, zhang b. Strahlenther Onkol. 2022 Sep;198(9):828-837. doi: 10.1007/s00066-022-01926-1. Epub 2022 Apr 6. Strahlenther Onkol. 2022. PMID: 35384452

10

Hypofractionated radiotherapy compared with conventionally fractionated radiotherapy to treat initial distant metastases in nasopharyngeal carcinoma: A multicenter, prospective, randomized, phase II trial.

Liu J, Zhang B, Su Y, Qin G, Kong X, Mo Y, Zhang R, Jiang W. Liu J, et al. Among authors: zhang b, zhang r. Radiother Oncol. 2023 Oct;187:109815. doi: 10.1016/j.radonc.2023.109815. Epub 2023 Jul 20. Radiother Oncol. 2023. PMID: 37480994 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39,205 results

Search Page